Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A phase II, open, single centre, exploratory study to evaluate the safety and immunogenicity of one booster dose of a GSK Biologicals’ Hepatitis B vaccine Engerix™-B or a of GSK Biologicals’ HIV candidate vaccine (732461), administered intramuscularly, in conjunction with the administration of a single oral dose of chloroquine in healthy adults https://kusajili.com:443/Trial/OkMbPzy1D0yVVd_5fyNWgg%24a-phase-ii-open-single-centre-exploratory-study-to-evaluate-the-safety-and-immunogenicity-of-one-booster-dose-of-a-gsk-biologic
I have read and accept the terms of use of the site and the Privacy Policy
Send your message